Brief: Sprint Bioscience AB Gets Financing From The Swedish Foundation For Strategic Research
21/10/2021 09:32
Oct 21 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* GETS FINANCING FROM THE SWEDISH FOUNDATION FOR STRATEGIC RESEARCH FOR THE IDENTIFICATION
OF NEW
MEDICINE TARGETS IN THE TREATMENT OF BLOOD CANCER
Source text for Eikon: ID:nWkrbfDjF3
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln